Anaphylaxis after intramuscular injection of diclofenac sodium

dc.authorid0000-0002-4302-1093
dc.authorid0000-0001-9151-6050
dc.authorid0000-0001-7325-6646
dc.authorid0000-0003-1045-0681
dc.contributor.authorColak, Sahin
dc.contributor.authorGunes, Harun
dc.contributor.authorAfacan, Mustafa Ahmet
dc.contributor.authorKandis, Hayati
dc.contributor.authorErdogan, Mehmet Ozgur
dc.contributor.authorAyranci, Mehmet
dc.contributor.authorSaritas, Ayhan
dc.date.accessioned2025-05-10T19:48:20Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractDiclofenac sodium is a 2-arylacetic acid, nonsteroidal anti-inflammatory drug. It is widely used in pain management. Side effects such as urticaria, asthmatic attack, vasospastic angina, ischemic stroke, and Kounis syndrome may be seen after the use of diclofenac sodium. However, anaphylactic shock is rare. Anaphylactic shock secondary to injection of diclofenac sodium can be treated successfully with intramuscular injection of adrenaline. Because diclofenac sodium is commonly used in analgesic treatment in emergency departments, we present this case report to emphasize that anaphylactic shock may be seen after the use of that drug.
dc.identifier.doi10.1016/j.ajem.2013.12.049
dc.identifier.issn0735-6757
dc.identifier.issn1532-8171
dc.identifier.issue7
dc.identifier.pmid24581886
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ajem.2013.12.049
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11680
dc.identifier.volume32
dc.identifier.wosWOS:000338222300007
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co-Elsevier Inc
dc.relation.ispartofAmerican Journal of Emergency Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleAnaphylaxis after intramuscular injection of diclofenac sodium
dc.typeArticle

Dosyalar